Merck & Company (MRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 15,624,000 | 16,657,000 | 16,112,000 | 15,775,000 | 14,631,000 |
| Cost of Goods | 3,828,000 | 4,080,000 | 3,745,000 | 3,540,000 | 3,912,000 |
| Gross Profit | 11,796,000 | 12,577,000 | 12,367,000 | 12,235,000 | 10,719,000 |
| Operating Expenses | 7,447,000 | 8,593,000 | 6,239,000 | 6,475,000 | 12,431,000 |
| Operating Income | 4,349,000 | 3,984,000 | 6,128,000 | 5,760,000 | -1,712,000 |
| Other Income | -179,000 | 106,000 | -122,000 | -90,000 | -334,000 |
| Pre-tax Income | 4,170,000 | 4,090,000 | 6,006,000 | 5,670,000 | -2,046,000 |
| Income Tax | 426,000 | 929,000 | 545,000 | 903,000 | -820,000 |
| Net Income Continuous | 3,744,000 | 3,161,000 | 5,461,000 | 4,767,000 | -1,226,000 |
| Minority Interests | 1,000 | 4,000 | 6,000 | 5,000 | N/A |
| Net Income | $3,743,000 | $3,157,000 | $5,455,000 | $4,762,000 | $-1,226,000 |
| EPS Basic Total Ops | 1.48 | 1.25 | 2.15 | 1.88 | -0.49 |
| EPS Basic Continuous Ops | 1.48 | 1.25 | 2.16 | 1.88 | -0.48 |
| EPS Diluted Total Ops | 1.49 | 1.24 | 2.14 | 1.87 | -0.48 |
| EPS Diluted Continuous Ops | 1.48 | 1.24 | 2.15 | 1.87 | -0.47 |
| EPS Diluted Before Non-Recurring Items | 1.72 | 1.57 | 2.28 | N/A | N/A |
| EBITDA(a) | $5,546,000 | $5,170,000 | $7,260,000 | $6,744,000 | $-748,000 |